India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Yes Bank 14.01
I T C Lt 235.30 13.21
Icici Ba 755.25 18.02
Vedl 348.50 31.86
Tata Mot 493.80 41.37
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs and Formulations
Market Lot: 1Face Value: 1ISIN Demat: INE044A01036
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
28-Oct-2021       Sun Pharma unveils drug to treat Plaque psoriasis in Canada IRIS
13-Oct-2021       Sun Pharma: Reaping the fruits of enhanced efforts in Specialty IRIS
08-Sep-2021       Sun Pharma forays into Nutrition Bar segment in India IRIS
03-Aug-2021       Sun Pharma: Superior performance across segments led to strong earnings beat  IRIS
30-Jun-2021       Pharma majors collaborate for clinical trial of Molnupiravir for Covid 19 IRIS
10-May-2021       Sun Pharma hits 52-week high on signing licensing agreement with Lilly IRIS
08-Mar-2021       Sun Pharma subsidiary to acquire 12.5% stake in WRS Bioproducts IRIS
26-Feb-2021       Sun Pharma launches website for its long-term care division IRIS
23-Feb-2021       Sun Pharma to introduce complete range of Brivaracetam drug in India IRIS
30-Mar-2020       Sun Pharma's Halol site classified for official action by USFDA IRIS
18-Jan-2019       Sun Pharma slips over 10% on buzz of fresh allegations by whistleblower IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited